Immunocore to present at upcoming investor conferences
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 27 May 2021) Immunocore (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infection and autoimmune disease, today announces that management will present at the following investor conferences in June.
Jefferies Virtual Healthcare Conference
Fireside Chat: Thursday, June 3, 2021 at 8:00 a.m. ET
Goldman Sachs 42nd Annual Global Healthcare Conference
Fireside Chat: Wednesday, June 9, 2021 at 10:30 am ET
The investor conferences will each be held in a virtual format and a live webcast of each fireside chat can be accessed in the ‘Investors’ section of Immunocore’s website at www.immunocore.com. For conferences that offer replays, presentations will be made available for a limited time.